Ceritinib Impurity 9 CAS CATO-C4X-10489
| CAS No. | CATO-C4X-10489 |
| Molecular Formula | C41H48Cl2N8O5S2 |
| Molecular Weight | 867.91 g/mol |
| Category | Pharmacopoeial Impurity Standards / EP Impurities |
| Availability | In Stock |
Chemical Structure
Description
Owing to a nitrogen-containing heterocyclic scaffold, an amide group, a sulfone group, a hydroxyl group, an ether linkage, chlorine substitution, Ceritinib Impurity 9 is typically pale yellow to yellow amorphous powder. Its solid-state physicochemical attributes — including a molecular weight of 867.91 g/mol — guide the selection of appropriate sample preparation and analytical techniques. Nitrogen-containing functional groups confer excellent ionization efficiency in positive-ion electrospray (ESI) mode, making the compound well suited to LC-MS/MS analysis.
CATO supplies Ceritinib Impurity 9 (CAS CATO-C4X-10489), a pharmacopoeial impurity reference standard (molecular formula C41H48Cl2N8O5S2, MW 867.91 g/mol) used for the identification and quantification of trace impurities in APIs.
Recommended for quantitative analysis by HPLC, GC, LC-MS/MS, or GC-MS as an external calibration standard; it can also be used for spiked-recovery experiments, LOD/LOQ determination, and LC-MS/MS multiple-reaction-monitoring (MRM) calibration.
CATO manufactures Ceritinib Impurity 9 under ISO 17034:2016 accreditation with dual CNAS and ANAB accreditation. Each batch is characterized by orthogonal methods and supplied with a full Certificate of Analysis (COA), ensuring metrological traceability.
Physical & Chemical Properties
| Molecular Formula | C41H48Cl2N8O5S2 |
| Molecular Weight | 867.91 g/mol |
| Purity | 97%+ |
| Storage | Store in a cool place (≤25°C), protect from light, keep sealed and dry |
| Solubility (reference) | Soluble in DMSO, DMF, methanol |
| Stability | May oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light; Hygroscopic; reseal immediately after opening; Contains ester bond; hydrolyzes under strong alkaline conditions |
| Degree of Unsaturation (DBE) | 21.0 |
| UV Absorption | UV-absorbing |
| Structural Features | Aromatic ring present |
| Halogen Content | Cl-containing |
| Nitrogen Atoms | 8 |
| Sulfur Atoms | 2 |
Related Ceritinib Standards
- Ceritinib Impurity 65 (CAS CATO-C4X-104865)
- Ceritinib Impurity 60 (CAS CATO-C4X-104860)
- Ceritinib Impurity 61 (CAS CATO-C4X-104861)
- Ceritinib Impurity 67 (CAS CATO-C4X-104867)
- Ceritinib Impurity 14 (CAS CATO-C4X-1048914)
- Ceritinib Impurity 75 (CAS CATO-C4X-104875)
- Ceritinib Impurity 11 (CAS CATO-C4X-1048911)
- Ceritinib Impurity 13 (CAS CATO-C4X-1048913)
Recommended Standards
- 2'-O-Methyl Paclitaxel (CAS 156413-67-1)
- Borate(1-), [(1R)-1-[[[(2-aminoethoxy)hydroxyphosphinyl]oxy]methyl]-2-[(1-oxohexadecyl)oxy]ethyl λ-(3,5-dimethyl-2H-pyrrol-2-ylidene-κN)-3,5-dimethyl-1H-pyrrole-2-dodecanoato(2-)-κN1]difluoro-, hydrogen (1:1), (T-4)- (CAS 1246355-64-5)
- Paclitaxel EP Impurity P (CAS 173101-56-9)
- 3',6'-Dibromo-2,2'',4,4''-tetramethyl-[1,1':4',1''-terphenyl]-2',5'-diyl bis(2-((2-isopropyl-5-methylcyclohexyl)oxy)acetate) (CAS 5465-55-4)
- Linezolid Impurity 65 (CAS CATO-C4X-107365)
- Vitamin K1 Impurity 68 (CAS CATO-C4X-220768)
- Ornidazole Impurity 87 (CAS CATO-C4X-133187)
- 2-Decanone (CAS 693-54-9)
- 8-Bromo-6-methyl-4-oxo-1,4-dihydrocinnoline-3-carboxylic acid (CAS 36991-61-4)
- Cyanocobalamin (Vitamin B12) (CAS 68-19-9)
- Thiazolo[5,4-b]pyridine (CAS 273-84-7)
- Ethyl 2-(4-(6-fluoroquinolin-4-yl)cyclohex-3-en-1-yl)acetate (CAS 1923836-86-5)
- BCTC (CAS 393514-24-4)
- Valosin Peptide (VQY), porcine (CAS 99510-37-9)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 18665070610 / Nicole.chen@cato-chem.com